Predictive Oncology Stock Forecast - Daily Balance Of Power
| POAI Stock | USD 1.15 0.15 11.54% |
Predictive Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Predictive Oncology stock prices and determine the direction of Predictive Oncology's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Predictive Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Predictive Oncology's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Predictive Oncology's systematic risk associated with finding meaningful patterns of Predictive Oncology fundamentals over time.
Check out Historical Fundamental Analysis of Predictive Oncology to cross-verify your projections. Predictive |
Most investors in Predictive Oncology cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Predictive Oncology's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Predictive Oncology's price structures and extracts relationships that further increase the generated results' accuracy.
Balance of Power indicator (or BOP) measures the strength of Predictive Oncology market sensitivity to bulls and bears. It estimates the ability of Predictive Oncology buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Predictive Oncology Balance of Power indicator one can determine a trend of the price direction.| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.65) | (0.58) |
| Check Predictive Oncology Volatility | Backtest Predictive Oncology | Information Ratio |
Predictive Oncology Trading Date Momentum
| On April 18 2024 Predictive Oncology was traded for 1.15 at the closing time. The top price for the day was 1.41 and the lowest listed price was 1.15 . The trading volume for the day was 67.1 K. The trading history from April 18, 2024 did not cause price change. The trading delta at closing time against the current closing price is 13.04% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Predictive Oncology to competition |
Other Forecasting Options for Predictive Oncology
For every potential investor in Predictive, whether a beginner or expert, Predictive Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Predictive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Predictive. Basic forecasting techniques help filter out the noise by identifying Predictive Oncology's price trends.Predictive Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Predictive Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Predictive Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Predictive Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Predictive Oncology Market Strength Events
Market strength indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By undertsting and applying Predictive Oncology stock market strength indicators, traders can identify Predictive Oncology entry and exit signals to maximize returns.
| Accumulation Distribution | 12369.91 | |||
| Daily Balance Of Power | (0.58) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 1.28 | |||
| Day Typical Price | 1.24 | |||
| Price Action Indicator | (0.21) | |||
| Period Momentum Indicator | (0.15) | |||
| Relative Strength Index | 98.87 |
Predictive Oncology Risk Indicators
The analysis of Predictive Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Predictive Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting predictive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.31 | |||
| Standard Deviation | 4.41 | |||
| Variance | 19.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Predictive Oncology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Historical Fundamental Analysis of Predictive Oncology to cross-verify your projections. For more detail on how to invest in Predictive Stock please use our How to Invest in Predictive Oncology guide.Note that the Predictive Oncology information on this page should be used as a complementary analysis to other Predictive Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Predictive Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Predictive Oncology. If investors know Predictive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Predictive Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.48) | Revenue Per Share 0.443 | Quarterly Revenue Growth (0.08) | Return On Assets (0.43) | Return On Equity (0.93) |
The market value of Predictive Oncology is measured differently than its book value, which is the value of Predictive that is recorded on the company's balance sheet. Investors also form their own opinion of Predictive Oncology's value that differs from its market value or its book value, called intrinsic value, which is Predictive Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Predictive Oncology's market value can be influenced by many factors that don't directly affect Predictive Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Predictive Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Predictive Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Predictive Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.